Colorectal cancer screening and surveillance

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Screening and surveillance substantially reduce both the incidence and mortality of colorectal cancer. Screening of normal-risk individuals may be accomplished by several methods, including fecal occult blood testing, fiberoptic sigmoidoscopy, double contrast barium enema, and colonoscopy. New technologies for screening are being developed, such as fecal immunochemical testing for blood, fecal DNA testing, and virtual colonoscopy. Patients at increased risk for colorectal cancer, such as those with a positive family history, previous adenomatous polyps or cancer, and inflammatory bowel disease, should be offered more intensive evaluation and surveillance.

Original languageEnglish (US)
Pages (from-to)1-20
Number of pages20
JournalSurgical Oncology Clinics of North America
Volume15
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Early Detection of Cancer
Colorectal Neoplasms
Computed Tomographic Colonography
Adenomatous Polyps
Sigmoidoscopy
Occult Blood
Colonoscopy
Inflammatory Bowel Diseases
Technology
Mortality
DNA
Incidence
Neoplasms
Barium Enema

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Colorectal cancer screening and surveillance. / Harford, William V.

In: Surgical Oncology Clinics of North America, Vol. 15, No. 1, 01.2006, p. 1-20.

Research output: Contribution to journalArticle

@article{988341052c9946f7b59576e73ed034b6,
title = "Colorectal cancer screening and surveillance",
abstract = "Screening and surveillance substantially reduce both the incidence and mortality of colorectal cancer. Screening of normal-risk individuals may be accomplished by several methods, including fecal occult blood testing, fiberoptic sigmoidoscopy, double contrast barium enema, and colonoscopy. New technologies for screening are being developed, such as fecal immunochemical testing for blood, fecal DNA testing, and virtual colonoscopy. Patients at increased risk for colorectal cancer, such as those with a positive family history, previous adenomatous polyps or cancer, and inflammatory bowel disease, should be offered more intensive evaluation and surveillance.",
author = "Harford, {William V.}",
year = "2006",
month = "1",
doi = "10.1016/j.soc.2005.11.003",
language = "English (US)",
volume = "15",
pages = "1--20",
journal = "Surgical Oncology Clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Colorectal cancer screening and surveillance

AU - Harford, William V.

PY - 2006/1

Y1 - 2006/1

N2 - Screening and surveillance substantially reduce both the incidence and mortality of colorectal cancer. Screening of normal-risk individuals may be accomplished by several methods, including fecal occult blood testing, fiberoptic sigmoidoscopy, double contrast barium enema, and colonoscopy. New technologies for screening are being developed, such as fecal immunochemical testing for blood, fecal DNA testing, and virtual colonoscopy. Patients at increased risk for colorectal cancer, such as those with a positive family history, previous adenomatous polyps or cancer, and inflammatory bowel disease, should be offered more intensive evaluation and surveillance.

AB - Screening and surveillance substantially reduce both the incidence and mortality of colorectal cancer. Screening of normal-risk individuals may be accomplished by several methods, including fecal occult blood testing, fiberoptic sigmoidoscopy, double contrast barium enema, and colonoscopy. New technologies for screening are being developed, such as fecal immunochemical testing for blood, fecal DNA testing, and virtual colonoscopy. Patients at increased risk for colorectal cancer, such as those with a positive family history, previous adenomatous polyps or cancer, and inflammatory bowel disease, should be offered more intensive evaluation and surveillance.

UR - http://www.scopus.com/inward/record.url?scp=29544447280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29544447280&partnerID=8YFLogxK

U2 - 10.1016/j.soc.2005.11.003

DO - 10.1016/j.soc.2005.11.003

M3 - Article

VL - 15

SP - 1

EP - 20

JO - Surgical Oncology Clinics of North America

JF - Surgical Oncology Clinics of North America

SN - 1055-3207

IS - 1

ER -